N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Professor H.K. Ng is a Chair Professor at the Chinese University of Hong Kong. His interests are in the molecular genetics of brain tumours, both adult and pediatric. He was previously Chairman of the Department of Anatomical and Cellular Pathology. H.K. Ng is both a neuropathologist and a general pathologist. He is a member of the Consensus Group of the 2007 and 2016 WHO classifications of brain tumours. He is also a member of cIMPACT-NOW, which is an extension of the WHO classification. For the WHO 2021 Classification, he was one of only 10 neuropathologists from around the world to have been selected for the Consensus Group. As an educationalist, H.K. was also Associate Dean (Education) of the Medical School of the Chinese University of Hong Kong from 2004 to 2019 and was Chair of the Licentiate Examination of the Hong Kong Medical Council. H.K. Ng was part of the team that received the 2nd Tier Award of The National Science and Technology Award of China in 2010 and the First Tier Science and Technology Award of Shanghai in 2019. He received the International Academy of Pathology Gold Medal twice in 2006 and 2017, and the HMRF Research Award of the Department of Health in 2021.

N/A

N/A

N/A

N/A

Dr. Anthony Pak-Yin Liu, MBBS, MMedSc, received his medical degree from the University of Hong Kong in 2009. He completed a residency in pediatrics and training in pediatric hematology/oncology at Queen Mary Hospital, Hong Kong, as well as a Master’s degree in genetic counseling. A keen clinician-scientist with an interest in pediatric central nervous system tumors, Dr Liu further trained as a Pediatric Neuro-Oncology Fellow at St. Jude Children’s Research Hospital, Memphis, TN, between 2017 and 2020 under the mentorship of Drs. Amar Gajjar and Paul Northcott. Dr. Anthony Liu joined the staff at The Hospital for Sick Children (SickKids) in 2024. His ongoing research is focused on biomarker development, circulating tumor material, and the molecular characterization of pediatric brain tumors, including medulloblastoma, pineoblastoma, and other embryonal tumors.

N/A